Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine infusion to exclude left atrial appendage thrombus in atrial fibrillation with severe spontaneous echo contrast
jRCTs031220544Completed
- Sponsor
- University of Tsukuba
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dobutamine in Atrial fibrillation (AFib) and cardioembolic stroke, sponsored by University of Tsukuba. Primary endpoint: Change in LA and LAA spontaneous echo contrast grade (investigator-assessed). Started Jan 2023; status: completed.
02
Drugs
dobutamine
03
Conditions
Atrial fibrillation (AFib)cardioembolic stroke
Beyond the preview
Go deeper on jRCTs031220544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220544.